Cargando…
Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma
Extranodal natural killer/T cell lymphoma, nasal type (ENKTL) is an aggressive lymphoid malignancy with a poor prognosis and lacks standard treatment. Targeted therapies are urgently needed. Here we systematically investigated the druggable mechanisms through chemogenomic screening and identified th...
Autores principales: | Liu, Chuanxu, Ding, Xinyu, Li, Gaoyang, Zhang, Youping, Shao, Yubao, Liu, Linyi, Zhang, Wenhao, Ma, Yujie, Guan, Wenbin, Wang, Lifeng, Xu, Zhongli, Chang, YungTing, Zhang, Yongqiang, Jiang, Biao, Yin, Qianqian, Tao, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393801/ https://www.ncbi.nlm.nih.gov/pubmed/37539026 http://dx.doi.org/10.1016/j.isci.2023.107369 |
Ejemplares similares
-
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
por: He, Yonghan, et al.
Publicado: (2020) -
Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020) -
Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022) -
Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
por: Wang, Jing-hua, et al.
Publicado: (2017) -
Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014)